Phreesia

PHR

Market cap $1.23B

The heavy selling pressure might have exhausted for Phreesia (PHR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been named to the 2025 Deloitte Technology Fast 500™.

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal third quarter 2026 financial results after the close of market trading on Monday, Dec. 8, 2025. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal third q.

The Capricorn Fund acquired 484,500 shares in Phreesia; estimated trade value of $11.40 million based on the average price during the quartea The trade represents 3.8% of 13F reportable AUM Post-trade stake totals 484,500 shares, valued at $11.40 million as of September 30, 2025 New position places Phreesia outside the fund's top five holdings

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been named to the 2025 Capterra Shortlists in the Appointment Reminder and Appointment Scheduling categories.

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been named to TIME's list of the World's Top HealthTech Companies of 2025.

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announces that Sara DiNardo, Vice President of Client Solutions, has been named in Becker's Hospital Review's 2025 list of Rising Stars.

Phreesia's stock fell post-earnings for the first time since June 2024 amid apparent disappointment with the company's largest-ever acquisition. Yet improving cash flow margin and net income trends continue to make the stock a buy. This non-cyclical growth story still has plenty of runway as the company works to expand into its large TAM opportunities.

Phreesia, Inc. PHR posted mixed results for the second quarter on Thursday.

Phreesia Inc. PHR shares slipped Friday despite a stronger-than-expected second quarter. The healthcare software firm posted earnings of 1 cent per share, topping forecasts for a 6 cent loss, while revenue rose 15% year-over-year to $117.26 million, ahead of estimates.